Cureus | Systemic Lupus Erythematosus and Cardiovascular Disease
Cureus | Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges
Managing Pain in Active or Well-Controlled Systemic Lupus Erythematosus
Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus | Lupus Science & Medicine
Correlation coefficient between disease activity markers, damage index... | Download Table
Biomarkers of Disease Activity | Musculoskeletal Key
![PDF] Predictors of outcome and immunological markers in patients with Systemic lupus erythematosus | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7b9974cb97432d247d83280bdd86acdf0954bf6d/52-Table1.4-1.png "PDF] Predictors of outcome and immunological markers in patients with Systemic lupus erythematosus | Semantic Scholar")
PDF] Predictors of outcome and immunological markers in patients with Systemic lupus erythematosus | Semantic Scholar
The Study of CD 69 as an Early Marker of SLE Activity in Pediatrics - SciAlert Responsive Version
Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease | PLOS ONE
Antibodies in SLE - YouTube
Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study - eClinicalMedicine
Biomarkers in systemic lupus erythematosus: II. Markers of disease activity - Illei - 2004 - Arthritis & Rheumatism - Wiley Online Library
Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus | Arthritis Research & Therapy | Full Text
Frontiers | Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
AVISE SLE Prognostic Test
Frontiers | Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus
Longitudinal Variation of Proteomic Biomarkers That Correlate with Efficacy Endpoints: Results from a Phase 3 Trial of Anifrolumab in Moderate to Severe Systemic Lupus Erythematosus - ACR Meeting Abstracts
Systemic lupus erythematosus: a clinical update - Connelly - 2021 - Internal Medicine Journal - Wiley Online Library
Systemic Lupus Erythematosus (SLE) - Cancer Therapy Advisor
![PDF] Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0fe7bbe7e3a7cf3e69d5a3040fb27a1477d84353/5-Table4-1.png "PDF] Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. | Semantic Scholar")
PDF] Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. | Semantic Scholar
Systemic Lupus Erythematosus | NEJM
A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex - C Terao, R Yamada, T Mimori, K Yamamoto,
